Side effects of radiation therapy reduced when computer optimizes treatment, study finds

A multi-center study found that breast cancer patients experienced less pain and skin irritation when a more complex form of treatment planning was used for radiation.

11:59 AM

Author | Mary Clare Fischer

woman in hospital gown going under scan machine in blue light
Getty Images

When a computer optimized the treatment plan for radiation therapy that was broken into multiple segments, known as inverse-planned, intensity-modulated radiotherapy, or IMRT, breast cancer patients were in less pain and experienced less skin irritation than when CT scans were used to deliver three-dimensional conformal radiation therapy, also know as 3DCRT.

That's according to findings by the Michigan Radiation Oncology Quality Consortium, a network of radiation treatment centers across the state that focuses on quality improvement.

Inverse planning allows for more complex treatment plans, with pixel-by-pixel variation, but has historically been more burdensome. These findings suggest, though, that the technique may help lessen the side effects of radiation therapy when used with IMRT.

However, whether to use more complex forms of IMRT for breast cancer patients involves weighing the expected benefit against costs, patient preferences, societal values and whether these methods end up giving low doses of radiation to regions like the other breast, the lung or the heart — an area that requires more research.

"This analysis from the Michigan Radiation Oncology Quality Consortium shows that radiation techniques that can limit doses to the skin of the breast can lead to less patient side effects," said Lori Pierce, M.D., professor of radiation oncology at the University of Michigan Medical School and the senior author of the study. "While use of IMRT may be one way to meet these constraints, we hope to better understand how other treatment approaches can be adapted to result in more uniform dose delivery and comparable side effects following breast irradiation."

Another aspect to consider is the use of hypofractionation, which involves giving larger doses of radiation at a time and therefore reduces the number of treatments patients receive; this option resulted in fewer side effects during the study as well.

"Creative efforts to promote appropriate use of moderate hypofractionation remain most essential, particularly given early observations of slow uptake of that approach," said Reshma Jagsi, M.D., D.Phil., the deputy chair of radiation oncology at Michigan Medicine and the lead author of the study.

Ultimately, this study adds nuance to the discussion of how to improve the quality of life for breast cancer patients receiving radiation, she adds.

"The acute side effects of radiation can cause significant distress for patients," Jagsi said. "There may even be long-term consequences for those who have had particularly severe acute toxicity during treatment. It is important that radiation oncologists do everything we can to make treatment tolerable for our patients. Our goal is not only to contribute to the cure of cancer but also to optimize our patients' ability to function throughout their treatment journey and beyond."

Additional authors include Kent A. Griffith, Margaret Grubb, James A. Hayman, Jean M. Moran, Martha M. Matuszak, and Robin Marsh of Michigan Medicine; Eyad Abu-Isa of Michigan Medicine and Providence Ascension; Joshua T. Dilworth and Danielle Lack of Beaumont Health; Michael M. Dominello of Karmanos Center Center at Wayne State University; David Heimburger of Munson Healthcare; Eleanor M. Walker of Henry Ford Health System; and Frank Vicini of GenesisCare.

Funding was provided by Blue Cross Blue Shield of Michigan and the Blue Care Network as part of the BCBSM Value Partnerships program.

Paper cited: "Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients," International Journal of Radiation Oncology - Biology - PhysicsDOI: 10.1016/j.ijrobp.2021.09.053


More Articles About: Lab Notes Cancer: Cancer Types Cancer Pain Radiation Oncology Cancer: Help, Diagnosis & Treatment
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories
Health Lab
Father’s cancerous brain tumor found weeks after the birth of his daughter
Father’s cancerous brain tumor found weeks after the birth of his daughter
Spilled pills next to a stethoscope and pile of cash
Health Lab
Drug pricing program improved prostate cancer treatment adherence
Socially vulnerable patients were more likely to stick with oral medications when treated at a hospital participating in 340B program, suggesting these hospitals may have more resources to help patients.
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
cancer cell blue yellow
Health Lab
Less chemoradiation is possible for some cancer patients
Some oropharynx cancer patients may qualify for less radiation treatments, according to a new study from experts at the University of Michigan Health Rogel Cancer Center.
Animated microscopic image of the glioblastoma's tumor microenvironment
Health Lab
New model of key brain tumor feature could help scientists understand how to develop new treatments
Model shows how oncostreams form and behave in brain tumors – and how to inhibit them
cancer cell blue yellow
Health Lab
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers